As of July 14, 2026, Serina Therapeutics, Inc. (SER) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Serina Therapeutics, Inc. has a market capitalization of $27.60M, 15.00M shares outstanding, 25 institutional holders tracked. Key dilution vectors include 54.0K outstanding warrants, approximately 24 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
29%
🔁 Convertible Conversion
40%
• Significant convertible debt: 18% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split
30%
• 50-day avg $1.98 approaching $1 threshold
💹 Market Data
Market Cap$27.60M
Shares Outstanding15.00M
Float8.42M
Cash$24.53M
Debt$11.15M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 259.7% shares (2026Q1 vs prior)
25 institutional holders · 1.61M shares
#1
Sio Capital Management, LLC
1.00M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
318.3K shares
#3
Waverly Advisors, LLC
67.5K shares
📉 Short Interest
Short Interest285.4K
Days to Cover3.5
% of Float3.4%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
Form 4
INSIDER TRANSACTION
Mar 23, 2026
Form 4
INSIDER TRANSACTION
Mar 19, 2026
Form 4
INSIDER TRANSACTION
Feb 02, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for SER Shareholders
Serina Therapeutics, Inc. (SER) has a DilutionScore of 50/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.
DilutionWatch's EDGAR monitoring for SER shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.
DilutionWatch tracks over 25 SEC filing types for SER in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for SER alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track SER Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SER — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for SER
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.